Michael Brundage

Michael Brundage, MD MSC FRCP(C) is a Professor Emeritus of Oncology and of Public Health Sciences at Queen’s University in Kingston. His research focuses on patient-reported outcomes and quality of life measurement (both in clinical practice and in clinical trials) and on quality of cancer care, with an emphasis on quality initiatives in oncology. He has enjoyed the privilege of working with many national and international organizations including the International Society for Quality of Life Research, the Canadian Cancer Trials Group (for which he was a long-standing chair of the PRO outcomes group), and Cancer Quality Council of Ontario. He is the Past-President of the Canadian Association of Radiation Oncology, and former director of Cancer Care and Epidemiology at Queen’s University. He is co-PI for the PROTEUS Consortium (with the PI Dr. Claire Snyder) which promotes quality of PROs both in clinical practice and clinical trials internationally.